New Requirement - Headspace GC-MS System

The Food and Drug Administration has announced a forecast for procuring a Headspace GC-MS System, classified under NAICS code 334516, which pertains to instruments manufacturing. This contract aims to fulfill a new requirement for advanced analytical instrumentation designed to enhance the agency’s capabilities in chemical analysis, likely for food safety, pharmaceuticals, or related regulatory applications. While specific details such as the solicitation number, place of performance, and set-aside status have not been provided, the announcement signifies the agency’s intent to invest in sophisticated gas chromatography-mass spectrometry technology that includes a headspace sampling feature. The contract information includes points of contact for acquisition inquiries, with an email listed for the acquisition liaison at the FDA, though the name and contact details for the contracting officer are yet to be assigned. The forecasted solicitation ensures interested vendors can prepare to engage with the FDA’s procurement process once the formal request for proposals or bids is issued. This opportunity reflects the FDA’s continuing commitment to maintain cutting-edge analytical tools to support its regulatory mission.